Shukra Jewellery (523790)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Price-to-book of 0.24 offers a steep 76% discount to book value of ₹26.43 per share.
• Piotroski F-score of 7/9 indicates a currently stable financial position.
• Small market cap of ₹9 crore leaves room for a potential value-unlocking event.
• Low entry price relative to stated assets provides a margin of safety on a balance-sheet basis.

Concerns

• Latest quarter shows zero sales and zero net profit, suggesting the core business is not operational.
• ROE of 1.55% and ROCE of 0.51% demonstrate weak returns on invested capital.
• No dividend yield, no sales/profit growth, and zero growth make it unappealing for income or compounding.
• Promoter holding is not disclosed, raising transparency and governance questions.

AI Analysis

Let me think like a value investor. I look for businesses I can understand, with durable competitive advantages and capable stewards of capital. Shukra Jewellery is a microcap in the gems and jewellery sector, but the numbers here are puzzling. The stock trades at ₹6.41 against a book value of ₹26.43 — a 76% discount. That means you are buying ₹100 of assets for ₹24. This is the kind of margin of safety Benjamin Graham taught. However, the business itself is barely earning anything. Return on equity is just 1.55% and return on capital employed is 0.51%. The latest quarter shows zero sales and zero net profit, and sales and profit growth are both flat. This is not an operating business compounding value; it is a bundle of assets generating no income. With no dividend, no growth, and promoter holding not disclosed, it fails several of my quality checks. The Piotroski F-score of 7/9 suggests the balance sheet is not deteriorating, but a fine score cannot replace earnings power. The P/E of 18.25 appears to be based on very small nominal earnings, and a PEG of 0.09 is meaningless when growth is zero. As a value investor, I would classify this as an asset play — you are buying at a deep discount to book, but the asset's ability to generate returns is weak. The market cap is only ₹9 crore, so there is little institutional oversight. I would wait for evidence of renewed sales and clear capital-allocation decisions before acting. For a small investor, this is speculative, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer